Remove 2014 Remove Conditions Remove Data
article thumbnail

Illinois releases Cannabis Report FY2024 (IDFPR portion)

Illinois News Joint

The 144-page report, compiled by the Cannabis Regulation Oversight Office (CROO), incorporates data from several state departments. Work with remaining conditional license-holders to transition to fully operational dispensaries serving both medical patients and adult use customers. Find detailed information about this topic here.)

article thumbnail

MDMA Failed to Receive FDA Approval: What Happens Next?

Veriheal

Drug company Lykos Therapeutics, which had filed the new drug application for MDMA therapy , was informed by the US Food and Drug Administration (FDA) that the data submitted was insufficient to receive approval, requesting that the company conduct an additional Phase 3 trial to further test the safety and efficacy of the drug.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Study: Daily Cannabis Use Among Pain Patients Associated with Less Non-Prescription Opioid Use

NORML

Patients suffering from persistent pain conditions who frequently use cannabis are far less likely to use non-prescription opioids, according to longitudinal data published in the journal PLOS One. Authors reported “an independent negative association between frequent cannabis use and frequent illicit opioid use.”

article thumbnail

Global Psychiatry Deals Report 2014-2021: Access to Headline, Upfront, Milestone and Royalty Data – ResearchAndMarkets.com

Cannabis Law Report

DUBLIN–(BUSINESS WIRE)–The “Global Psychiatry Partnering 2014-2021: Deal trends, players and financials” report has been added to ResearchAndMarkets.com’s offering. Trends in Psychiatry dealmaking in the biopharma industry since 2014. Trends in Psychiatry dealmaking in the biopharma industry since 2014.

Access 40
article thumbnail

The most common reasons people get medical marijuana cards: 2021 edition

The Cannigma

In these three dozen states, from the West Coast to the Midwest to the South and the Northeast, patients use cannabis to treat countless medical conditions and everyday ailments. of patients reported chronic pain as their primary condition, while in Connecticut 70.4% The most common medical conditions. In Colorado, 78.7%

article thumbnail

Medical Marijuana: An Alternative Treatment for Depression?

FloridaMarijuana.net

The study’s data showed that “Cannabis significantly reduced ratings of depression, anxiety, and stress.” Participants in the study recorded their personal experience when using cannabis for their depression and other mental conditions such as anxiety and stress; scientists were able to use data collected from the app to analyze the results.

Treatment 100
article thumbnail

Study Finds No Correlation Between Cannabis Legalization and Increased Mental Illness

Veriheal

Those who support cannabis have used the evidence of its ability to treat mental conditions like post-traumatic stress disorder (PTSD) to rebuke claims of a link between cannabis and mental illness. While the research from 2014 that nullifies anti-legalization advocates’ claims is now supported by the study conducted by Singer et al.,